Valuation : Illumina, Inc.

Market Cap 33.47B 28.8B 27.1B 24.75B 46.31B 3,160B 46.43B 320B 124B 1,621B 126B 123B 5,223B P/E 2026 *
44.8x
P/E 2027 * 37.9x
Enterprise Value 33.72B 29.01B 27.3B 24.94B 46.65B 3,183B 46.78B 323B 125B 1,633B 127B 124B 5,262B EV / Sales 2026 *
7.29x
EV / Sales 2027 * 6.67x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day-1.69%
1 week+1.07%
Current month+2.00%
1 month+7.33%
3 months+29.66%
6 months+68.95%
Current year+66.13%
1 week 206.82
Extreme 206.82
221.76
1 month 186.64
Extreme 186.64
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
469.87
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26
Corvex Management LP
SellCompany -138,379 0.0915%
25/08/26 Other

Director

0 0%
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
Change 5-day change 1-year change 3-year change Capi.($)
-1.69%+1.07%+123.08%+36.67% 33.47B
-0.83%-1.49%+25.22%+13.08% 229B
-1.91%-4.15%+4.05%-20.61% 148B
-1.52%-2.24%-19.86%+18.39% 131B
+1.30%+1.49%-55.69%-10.81% 68.04B
-0.03%-0.67%+10.68%+17.95% 51.75B
+0.49%-1.32%-17.27%-14.42% 50.21B
+0.48%-2.09%+17.23%+26.86% 42.28B
-0.75%-0.93%+37.09%+48.67% 40.63B
-1.00%-5.65%-17.18%+47.35% 33.06B
Average -0.54%-1.73%+10.74%+16.32% 82.71B
Weighted average by Cap. -0.80%-1.92%+6.60%+9.33%

Financials

2026 *2027 *
Net sales 4.62B 3.98B 3.74B 3.42B 6.4B 437B 6.42B 44.24B 17.17B 224B 17.37B 16.99B 722B 4.91B 4.23B 3.98B 3.63B 6.79B 464B 6.81B 46.98B 18.23B 238B 18.44B 18.04B 766B
Net income 760M 654M 616M 562M 1.05B 71.79B 1.05B 7.27B 2.82B 36.83B 2.86B 2.79B 119B 891M 767M 722M 659M 1.23B 84.15B 1.24B 8.53B 3.31B 43.17B 3.35B 3.27B 139B
Net Debt 246M 212M 199M 182M 340M 23.23B 341M 2.35B 913M 11.92B 924M 904M 38.39B -729M -627M -590M -539M -1.01B -68.83B -1.01B -6.97B -2.71B -35.31B -2.74B -2.68B -114B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
04/09/26 US$217.86 -1.71% 721,380
03/09/26 US$221.66 +3.94% 1,716,855
02/09/26 US$213.25 +2.95% 1,771,946
01/09/26 US$207.13 -3.04% 1,501,398
31/08/26 US$213.63 -0.91% 2,017,763
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
221.66USD
Average target price
199.63USD
Spread / Average Target
-9.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock